Clinical Trials Sponsored by Army Research and Referral hospital

Total 4549 results

Duke University
Moi Teaching and Referral Hospital

Completed

Cardiac Rehabilitation and Metabolomics in Heart Failure (CROMe)

Heart Failure

Kenya
Duke University
Moi Teaching and Referral Hospital

Completed

Feasibility of Cardiac Rehabilitation in Patients With Heart Failure at the Moi Teaching and Referral Hospital (FCR-HF)

Heart Failure

Kenya
Sanjay Gandhi Postgraduate Institute of Medical...
Postgraduate Institute of Medical Education and Research; Institute of Postgraduate... and other collaborators

Completed

A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Scleroderma | Raynaud's Phenomenon | Digital Ulcers

India
Madigan Army Medical Center
U.S. Army Medical Research and Development Command

Terminated

Medical Therapies for Chronic Post-Traumatic Headaches

Headache

United States
Walter Reed Army Institute of Research (WRAIR)
U.S. Army Medical Research and Development Command; U.S. Army Training and...

Completed

Evaluation of Mindfulness and Yoga in Basic Combat Training

Pain | Stress | Health, Subjective | Sleep | Anxiety | Depressive Symptoms | Mood | Leadership | Emotion Regulation | Yoga | Mindfulness | Musculoskeletal Injury | Military Operations | Cohesion, Social

United States
U.S. Army Medical Research and Development Command

Recruiting

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome

Hantaan Virus Nephropathy | Puumala Virus Nephropathy

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
U.S. Army Medical Research and Development Command

Available

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Smallpox | Monkeypox
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

Malaria,Falciparum

United States
U.S. Army Medical Research and Development Command

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine (VEE TC-83)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Withdrawn

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

Malaria

United States
U.S. Army Medical Research and Development Command

Withdrawn

Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany (HFRS)

Hemorrhagic Fever With Renal Syndrome

Germany
U.S. Army Medical Research and Development Command

Completed

A Double-Blind, Randomized, Placebo Controlled, Clinical Trial of an Antiplaque Chewing Gum (30 mg) - Phase 2 Proof of Concept in a Generally Healthy Patient Population (APCG)

Plaque Regrowth
U.S. Army Medical Research and Development Command

Withdrawn

Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Study of the Safety of Intravenous Artesunate

Malaria | Malaria, Cerebral

United States
U.S. Army Medical Research and Development Command

Completed

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Leishmaniasis, Cutaneous

Peru
U.S. Army Medical Research and Development Command

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Completed

Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) (HOPPS)

Traumatic Brain Injury | Post-concussive Symptoms

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Recruiting

A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

Vaccine Reaction

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

HIV Infections

United States
U.S. Army Medical Research and Development Command

Not yet recruiting

Treatment of Hemorrhagic Fever With Ribavirin

Hemorrhagic Fever
U.S. Army Medical Research and Development Command

No longer available

Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)

Severe Acute Respiratory Syndrome Coronavirus 2

United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
U.S. Army Medical Research and Development Command

Active, not recruiting

Combination HTNV and PUUV DNA Vaccine

Hantaan Virus Disease, Puumala Virus

United States
U.S. Army Medical Research and Development Command

No longer available

Expanded Access Remdesivir (RDV; GS-5734™)

Coronavirus Disease 2019

United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

Thrombocytopenia

United States
U.S. Army Medical Research and Development Command

Enrolling by invitation

Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
U.S. Army Medical Research and Development Command

Completed

Ascending Doses of Autologous FDP vs FFP (FDP)

Freeze Dried Plasma in Healthy Volunteers

United States
U.S. Army Medical Research and Development Command

Completed

A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis

Old World Cutaneous Leishmaniasis

Tunisia
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 (VEE C-84)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Enrolling by invitation

Ribavirin for Hemorrhagic Fever With Renal Syndrome

Hemorrhagic Fever With Renal Syndrome

Korea, Republic of
U.S. Army Medical Research and Development Command

No longer available

Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population (APCG)

Gingivitis | Plaque

United States
U.S. Army Medical Research and Development Command

Completed

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine (MP-12)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms (BIMA)

Post-Concussion Syndrome | Traumatic Brain Injury With Brief Loss of Consciousness

United States
U.S. Army Medical Research and Development Command

Completed

TDENV PIV and LAV Dengue Prime-boost Strategy

Dengue

United States
U.S. Army Medical Research and Development Command

Completed

Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama

Cutaneous Leishmaniasis

Panama
U.S. Army Medical Research and Development Command

Withdrawn

Phase 1 meCS6 + LT(R192G) Vaccine Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama

Leishmaniasis, Cutaneous

Panama
U.S. Army Medical Research and Development Command

Completed

Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease (DENV-1 PIV)

Dengue Fever

United States
U.S. Army Medical Research and Development Command

Completed

Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)

Cutaneous Leishmaniasis

Tunisia
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center

Terminated

Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396

Cutaneous Leishmaniasis

United States
Madigan Army Medical Center
U.S. Army Medical Research and Development Command; William Beaumont Army Medical...

Completed

Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back Pain (COMPETE)

Low Back Pain

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Malaria

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Study of the Safety of Intravenous Artesunate

Malaria | Malaria, Cerebral

United States

Clinical Trials Sponsored by Army Research and Referral hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations